Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tetrandrine for Targeting Therapy Resistance in Cancer.
Lima EN, Lamichhane S, Pramod KC, Ferreira ES, Koul HK, Koul S. Lima EN, et al. Among authors: koul hk. Curr Top Med Chem. 2024 Mar 5. doi: 10.2174/0115680266282360240222062032. Online ahead of print. Curr Top Med Chem. 2024. PMID: 38445699
Regulation of SPDEF expression by DNA methylation in advanced prostate cancer.
Vatanmakanian M, Steffan JJ, Koul S, Ochoa AC, Chaturvedi LS, Koul HK. Vatanmakanian M, et al. Among authors: koul hk. Front Endocrinol (Lausanne). 2023 Oct 11;14:1156120. doi: 10.3389/fendo.2023.1156120. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37900138 Free PMC article.
Retraction Note: Hypoxia-associated p38 mitogen-activated protein kinase-mediated androgen receptor activation and increased HIF-1α levels contribute to emergence of an aggressive phenotype in prostate cancer.
Khandrika L, Lieberman R, Koul S, Kumar B, Maroni P, Chandhoke R, Meacham RB, Koul HK. Khandrika L, et al. Among authors: koul hk. Oncogene. 2022 Jun;41(24):3383. doi: 10.1038/s41388-022-02357-z. Oncogene. 2022. PMID: 35589952 Free PMC article. No abstract available.
Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells.
Dean MJ, Ochoa JB, Sanchez-Pino MD, Zabaleta J, Garai J, Del Valle L, Wyczechowska D, Baiamonte LB, Philbrook P, Majumder R, Vander Heide RS, Dunkenberger L, Thylur RP, Nossaman B, Roberts WM, Chapple AG, Wu J, Hicks C, Collins J, Luke B, Johnson R, Koul HK, Rees CA, Morris CR, Garcia-Diaz J, Ochoa AC. Dean MJ, et al. Among authors: koul hk. Front Immunol. 2021 Jul 14;12:695972. doi: 10.3389/fimmu.2021.695972. eCollection 2021. Front Immunol. 2021. PMID: 34341659 Free PMC article.
66 results